13
Oct
Oct
In a recent study posted to medRxiv preprint* server, researchers at pharmaceutical and biotechnology company Moderna, Inc. estimated the economic and clinical impact of updated messenger ribonucleic acid (mRNA) vaccines for coronavirus disease 2019 (COVID-19). Study: Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany. Image Credit: etraveler / Shutterstock *Essential notice: […]